Aug 2, 2011

Lung carcinoma signaling pathways activated by smoking

Chinese Journal of Cancer
Jing WenMing Guo

Abstract

Lung cancer is the leading cause of cancer death in men and women worldwide, with over a million deaths annually. Tobacco smoke is the major etiologic risk factor for lung cancer in current or previous smokers and has been strongly related to certain types of lung cancer, such as small cell lung carcinoma and squamous cell lung carcinoma. In recent years, there has been an increased incidence of lung adenocarcinoma. This change is strongly associated with changes in smoking behavior and cigarette design. Carcinogens present in tobacco products and their intermediate metabolites can activate multiple signaling pathways that contribute to lung cancer carcinogenesis. In this review, we summarize the smoking-activated signaling pathways involved in lung cancer.

  • References63
  • Citations11

References

  • References63
  • Citations11

Citations

Mentioned in this Paper

Biochemical Pathway
Adenocarcinoma of Lung (Disorder)
Tobacco
Nicotiana
Small Cell Carcinoma of Lung
Carcinoma of Lung
Beta-adrenergic receptor
Epidermal Growth Factor Receptor
Squamous Cell Carcinoma
Squamous Cell Carcinoma of Lung

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.